Discontinued — last reported Q4 '25
Eli Lilly Total Current Assets decreased by 10.4% to $55.63B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 69.9%, from $32.74B to $55.63B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 26.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
A high ratio of current assets to current liabilities indicates strong short-term solvency and financial health.
The sum of all assets expected to be converted into cash or consumed within one fiscal year. This provides a snapshot of...
Used to calculate the Current Ratio, a standard benchmark for liquidity across the S&P 500.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.30B | $17.81B | $18.45B | $16.96B | $17.12B | $17.64B | $18.03B | $20.81B | $21.33B | $23.01B | $25.73B | $25.19B | $30.20B | $31.42B | $32.74B | $41.26B | $49.85B | $62.07B | $55.63B |
| QoQ Change | — | +3.0% | +3.6% | -8.1% | +0.9% | +3.1% | +2.2% | +15.4% | +2.5% | +7.9% | +11.8% | -2.1% | +19.9% | +4.0% | +4.2% | +26.0% | +20.8% | +24.5% | -10.4% |
| YoY Change | — | — | — | — | -1.0% | -0.9% | -2.3% | +22.7% | +24.6% | +30.4% | +42.7% | +21.0% | +41.6% | +36.5% | +27.3% | +63.8% | +65.1% | +97.6% | +69.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.